Not to say that India couldn't have handled the situation better, but on average, it didn't do anywhere near as badly as the naysayers make it out argues Rajeev Srinivasan.
Maharashtra Chief Minister Uddhav Thackeray announced a statewide curfew for 15 days from 8 am on April 14 to contain the rapid spread of the coronavirus in its second wave. With Section 144 being imposed across the state, Thackeray essential services have been exempted from the restrictions. The curfew will be in place till 7 am on May 1.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
While Nifty 50 reflects changes in 40 years, it also shows what is missing: Low-cost manufacturers at one end, and deep-value players at the other. Also missing are technology players, observes T N Ninan.
Initial share sales are set to dazzle the Dalal Street in 2022 too as companies are expected to garner up to Rs 1.5 lakh crore in the New Year, continuing with the bullish momentum after 2021 turned out to be the best IPO year in two decades for the Indian market. Excessive liquidity and increased retail investor participation ensured a persistent euphoria in the Initial Public Offer (IPO) space wherein companies mopped up more than Rs 1.2 lakh crore this year even as pandemic gloom shadowed the broader economy. In 2022, the higher amount of funds through the primary market will be largely driven by the mega IPO of state-owned Life Insurance Corp (LIC).
The phased reopening and regulated relaxations of many key industries have paved the way for a slight recovery in hiring activities but hiring is still down by 47 per cent in July 2020 compared to the same month last year.
AstraZeneca Plc and the University of Oxford are facing questions about their Covid-19 vaccine and whether regulators would quickly authorise its emergency use after the pharma company acknowledged an error in the vaccine dosage received by some participants and other irregularities and omissions, according to the New York Times.
"They are extending support as they feel that this is the time we must help India. 'India has helped us and we must help India'. So I do not think we are looking at it in policy terms," the foreign secretary said.
The recent US-India friction over trade is being driven by Big Pharma.
Pharma shares extended losses after the government's ban on combination drugs.
Blood samples taken from a group of UK volunteers given a dose of the vaccine showed that it stimulated the body to produce both antibodies and 'killer T-cells', a senior source from the trial was quoted by The Daily Telegraph as saying.
The situation is severe in North India as most of the logistics operation was manned by migrant labourers from Uttar Pradesh and Bihar. The problem with manpower is not only in courier and delivery services, but also at a shop level.
The growth was led by family-owned companies and business groups with presence in pharmaceuticals, information technology services, and consumer products.
Pharma shares were the top gainers led by Lupin after the company received EIR from USFDA for its Goa facility
Top laggards in the Sensex pack included HDFC, ICICI Bank, TCS, HCL Tech, Kotak Bank, Asian Paints, TechM and HUL, dropping up to 2.67 per cent.
The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.
The 30-share Sensex ended down 215 points at 27,011.
'What has gained prominence are 'human' skills like creativity, originality and initiative, critical thinking, persuasion, and negotiation, as well as attention to detail, resilience, flexibility and complex problem-solving.'
'When there is so much anxiety, the Government of India should assure people on the vaccine issue and help the states demanding more supply that they will be provided the required quantities.' 'Any Centre-state conflict at this point of time is counter-productive and enhances people's anxieties that should be avoided.'
Surat resident Ashfaq Shaikh, a prime suspect, allegedly replaced his colleague Rohit Solanki's photo on the latter's Aadhaar card with his own. He also changed the birth date on the Aadhaar card.
"Essential services will continue to be available and people should not have any misunderstanding or confusion regarding this. Medical shops and pharma companies will continue to function as usual," Thackeray said.
The Tata Sons' chief said that world's reliance on China for sourcing goods will reduce, and India will definitely have an opportunity to participate.
The Institute of Chartered Financial Analysts of India University, Tripura's master degree programs based on self-study and examinations.
India's biggest firm, Reliance Industries, has decided to cut salaries by 10 per cent in its oil and refining divisions. Several smaller companies like Kajaria Ceramics have followed suit with cuts as high as 40 per cent for those earning more than Rs 50 lakh.
'The vast majority of people are going to get better.' 'And the small fraction, who are not going to get better, unfortunately, there's no drug that we have that can that can alter the trajectory.'
An extensive analysis of the available results of companies for the just-concluded fourth quarter shows robust growth in sales and profit, carrying forward the momentum from earlier quarters.
Inspections only in domestic authorities' presence, visiting US drug regulator told
Ajit Mishra, vice president, Research, Religare Broking, answers readers' queries on stocks they own or want to buy.
The BSE Midcap and the BSE Smallcap indices pared all intraday gains to end 0.3% and 0.5% lower
Part of landing your dream job involves knowing the ins and outs of that particular job.
Australian health regulator Therapeutic Goods Administration is investigating Indian pharma major Ranbaxy, following US allegations of the company falsifying data and test results of new drug applications, a media report says.
Sensex eneded lower on poor perfromance by financials and IT stocks.
Earlier this week, the company postponed the announcement of its results for the year-ended December 31, 2008, as the statutory audit could not be completed because of restructuring of certain of its businesses and subsidiaries. In a major top management rejig, the company's chairman and managing director Habil Khorakiwala, stepped down as managing director.
The world is home to a record number of 2,089 billionaires.
USFDA issues Form 483 with as many as 14 observations that could impact ongoing operations at Aurobindo's Pashamailaram facility in Hyderabad.
A day after Ranbaxy Laboratories accused corporate rivals for the recent stock slump, the pharma major on Thursday said its deal to sell promoters' stake to the Japanese firm Daiichi Sankyo is 'binding and final.'
Kotak Mahindra Bank was the biggest gainer on both the indices, ending nearly 9 per cent higher following reports that Warren Buffett's Berkshire Hathaway Inc was planning to pick up stake in the private sector lender.
The 30-share Sensex ended down 224 points at 28,442 and the 50-share Nifty ended down 101 points at 8,606.
Any concerned citizen ought to start practicing hygiene by washing their hands properly and be aware of the brands that are certified.
Market players said a big upmove by the market will depend on policy action by the government to revive economic growth and corporate earnings revival.
